Navigation Links
Pharsight Achieves $7.6 Million In Quarterly Revenue
Date:5/8/2008

grew 12% year-over-year and we entered into 10 new agreements during the quarter," said Mr. O'Connor. "Our RAS offering, now staffed with 12 people, generated 86% sequential revenue growth over the fiscal third quarter."

"During fiscal 2008, we positioned Pharsight for accelerated long term growth," added Mr. O'Connor. "We strengthened our balance sheet, continued to make investments in our product development and infrastructure and expanded our consulting service offerings. Based on the progress made during the past year, we are able to forecast a higher revenue growth rate for fiscal 2009. In addition, we believe that we will generate increased operating margins and enhanced profitability for the full fiscal year."

Recent Highlights

Pharsight's recent highlights in its software and consulting services businesses include:

Software

-- Achieved 14% revenue growth in fiscal 2008 compared with fiscal 2007.

-- Added 22nd PKS customer.

-- Achieved sixth WinNonlin AutoPilot customer within first nine months

since product launch.

-- Added two new DMX customers to bring total to eleven.

Consulting Services

Strategic Consulting Services (SCS)

-- Continued to diversify revenue base with top five customers

representing 59% of revenue compared with 82% in the same period last

fiscal year.

-- Engaged four new customers.

-- Continued to make featured presentations at key industry meetings

including the American Society for Clinical Pharmacology and

Therapeutics (ASCPT) and the American Conference on Pharmacometrics

(ACoP)

Reporting and Analysis Services (RAS)

-- Engaged six new customers.

-- Integrated PKS with WinNonlin and AutoPilot in a validated solution for

regulatory studies.

-- Expanded the RAS team in response to global demand for the group's

services; team now totals 12 professiona
'/>"/>

SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Pharsight Signs Two New DMX(R) License Customers
2. Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference
3. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
4. Pharsights Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System
5. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
6. Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
7. Pharsight Achieves $7.4 Million in Quarterly Revenue
8. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
9. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
10. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
11. Pharsight Announces 1-For-3 Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... -- Senomyx , Inc. (NASDAQ: SNMX ... discover, develop, and commercialize novel flavor ingredients, announced today ... Company,s Vice President, Biology and Gwen Rosenberg ... will present an overview of Senomyx,s technology and programs ... (7:25 a.m. Pacific Time) during the Citi 2013 Global ...
(Date:5/24/2013)... 24, 2013 Many factors impact tissues ... or efflux transporters at the blood-tissue barrier. Even when ... unbound fractions in the tissue rather than the total ... challenges is required to guide lead optimization, predict in ... species-dependent variables that may impact the likely human clinical ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Vestiage, ... lifestyle company focused on science-based research and development, ... anti-aging cosmeceuticals and nutraceuticals, announced today that it ... States for the sale of Reluma Skin Illuminating ... packet and application by sending an email to ...
(Date:5/23/2013)... , May 24, 2013 Die ... – Bei der englischen Version ... , 91 % der Teilnehmer einer groß angelegten Asthmaumfrage ... % laut GINA [*] -Definition [1] als kontrolliert ... mit Asthma generell einer von vier Denkweisen zugeordnet werden ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7
... and Products Offset Patent Expirations, SAN FRANCISCO, ... of major neuropathic pain (NP) conditions is currently ... a report released today by,WWMR, Inc. Growth over ... by the,successful launch of Lyrica (pregabalin) for diabetic ...
... in Pharmaceutical Thin Film,Technology -, WARREN, N.J., ... specializing in quick dissolving thin film pharmaceutical products,today ... No. 7,425,292 from the,United States Patent and Trademark ... to issue on September 16, 2008, relates,to the ...
... 11 BioTrends Research Group, Inc. is,pleased to announce ... report in a series conducted with Anemia Managers. It ... by 150 Anemia Managers,-- 100 working with dialysis patients ... patients, and qualitative interviews with a,subset of 25 respondents. ...
Cached Biology Technology:US Neuropathic Pain Market Value Doubles to $5 Billion by 2018 2US Neuropathic Pain Market Value Doubles to $5 Billion by 2018 3MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 2MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 3New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices 2New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices 3
(Date:5/22/2013)... to improve durability in fuel cell powered buses, ... discovered links between electrode degradation processes and bus ... effects of electrode degradation stressors in the operating ... , The findings of the study, led by ... in a long-term study at Burnaby-based Ballard Power ...
(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...
(Date:5/22/2013)... whole organism, as they may lead to life-threatening illnesses ... report how byproducts of respiration cause mispairing of subunits ... cells controls the form and function of every cell ... encoded in the linear sequence of the four subunits ... guanine (G) and thymine (T). Random changes in the ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2Fish oil may help the heart beat mental stress 2DNA damage: The dark side of respiration 2
... Des Moines, Iowa March 1, 2010 You ... three language-competent bonobos living at Great Ape Trust, than you ... day tell scientists more about the effect of culture on ... is a universal language, an alternative to spoken words to ...
... years on Down,s syndrome has focused on the DYRK1A ... the neurones, according to Mr Garikoitz Azkona. In his ... Down,s syndrome: the role of DYRK1A , Mr Azkona ... behind the problem that persons with Down,s syndrome have ...
... well known for keeping us healthy as it is for ... new research report appearing in the March 2010 print issue ... explain how they developed a genetically modified strain of tobacco ... scientifically known as microcystin-LR (MC-LR), which makes water unsafe for ...
Cached Biology News:If bonobo Kanzi can point as humans do, what other similarities can rearing reveal? 2If bonobo Kanzi can point as humans do, what other similarities can rearing reveal? 3DYRK1A gene may be 1 of most influential factors in Down syndrome 2
... SAPK/JNK (Thr183/Tyr185) Antibody Kit Kit ... Catalog #9251, 200 ul SAPK/JNK (56G8) ... SAPK/JNK Cell Extracts, Catalog #9253, (4 ... Catalog #7074, 100 ul Anti-biotin IgG, ...
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Biology Products: